You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fallopian tube cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (Huaier granule)

Not yet recruiting
  • Primary Ovarian Cancer
  • +2 more
  • Huaier granule
  • (no location specified)
Mar 29, 2023

A Prospective, Randomized Controlled Study of Cyclophosphamide,

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Shijiazhuang, Hebei, China
    Hebei
Aug 20, 2023

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Minneapolis, Minnesota
  • +1 more
Jan 27, 2023

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

Not yet recruiting
  • Stage III Ovarian Cancer
  • +5 more
  • (no location specified)
Dec 12, 2022

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (NY-ESO-1 peptide vaccine)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • NY-ESO-1 peptide vaccine
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
May 30, 2023

Cancer, Solid Tumor, Ovarian Cancer Trial in Minneapolis (FT538, Enoblituzumab)

Not yet recruiting
  • Cancer
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center - University of Minnesota
Jan 24, 2023

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
May 12, 2023

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (Microdevice)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Microdevice
  • Boston, Massachusetts
  • +1 more
Jul 12, 2022

Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

Not yet recruiting
  • Ovarian Cancer
  • +5 more
  • MIRRORS Protocol
  • Standard Open Cytoreductive Surgery
  • (no location specified)
Jul 17, 2023

Total Management of Ovarian Cancer

Not yet recruiting
  • Tumor of Female Reproductive System
  • Ovarian Cancer
  • No intervention
  • (no location specified)
Aug 30, 2023

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Houston, Texas
  • +4 more
Oct 20, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +6 more
  • Biopsy
  • Pegylated SN-38 Conjugate PLX038
  • Rochester, Minnesota
    Mayo Clinic
Jul 19, 2022

Homologous Recombination Inquiry Through Ovarian Malignancy

Completed
  • Ovarian Cancer
  • +2 more
    • Niigata city, Niigata Prefecture, Japan
      Niigata University Graduate School of Medical and Dental Science
    Jan 19, 2023

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • Odense, Denmark
    • +3 more
    Oct 16, 2023

    BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic

    Recruiting
    • BRCA-Mutated Ovarian Carcinoma
    • +30 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 27, 2022

    Cervical Cancer, Endometrial Cancer, Ovarian Cancer Trial in Seoul (Patient registry)

    Recruiting
    • Cervical Cancer
    • +4 more
    • Patient registry
    • Seoul, Korea, Republic of
      Department of Obstetrics and Gynecology, University of Ulsan Col
    Jun 12, 2023

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

    Active, not recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • New Haven, Connecticut
    • +1 more
    Jan 11, 2023

    Effectiveness in Ovarian Cancer

    Completed
    • Ovarian Cancer
    • +5 more
    • Baseline Biopsy
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 24, 2023

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • New Orleans, Louisiana
    • +3 more
    Dec 16, 2022